CSA
TAK icon

Cornerstone Select Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Cornerstone Select Advisors’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$213K Sell
11,492
-98
-0.8% -$1.72K 0.13% 115
2025
Q4 		$181K Buy
11,590
+105
+0.9% +$1.5K 0.13% 115
2025
Q3 		$168K Hold
11,485
– – 0.12% 108
2025
Q2 		$178K Hold
11,485
– – 0.16% 108
2025
Q1 		$171K Sell
11,485
-1,130
-9% -$15.8K 0.16% 108
2024
Q4 		$167K Buy
+12,615
New +$173K 0.16% 110

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cornerstone Select Advisors's TAK Position: Q1 2026 in Review

Cornerstone Select Advisors reduced its Takeda Pharmaceutical (TAK) stake by 0.85% in Q1 2026, selling an estimated $1.72K and leaving 11,492 shares worth $213K. The position accounts for 0.13% of the portfolio, ranked #115.

Cornerstone Select Advisors first reported a position in TAK in Q4 2024 and has held it in 6 quarters since. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • Cornerstone Select Advisors held 11,492 shares of Takeda Pharmaceutical worth $213K as of Q1 2026.
  • Cornerstone Select Advisors sold 98 Takeda Pharmaceutical shares in Q1 2026, an estimated $1.72K.
  • Takeda Pharmaceutical made up 0.13% of Cornerstone Select Advisors's portfolio in Q1 2026, its #115 holding.
  • Cornerstone Select Advisors first reported a position in Takeda Pharmaceutical in Q4 2024 and has held it in 6 quarters since.
  • 358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Cornerstone Select Advisors's 13F filing for Q1 2026, filed 13 May 2026.